Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 05, 2026
Salesforce (CRM) vs Atlassian (TEAM): Weighing +34% and +74% Monthly Rebounds

Salesforce (CRM) vs Atlassian (TEAM): Weighing +34% and +74% Monthly Rebounds

Key Takeaways

  • Salesforce (CRM) is a mature, highly profitable enterprise software leader, while Atlassian (TEAM) is a faster-growing collaboration-software player earlier in its cloud transition.
  • Both stocks fell sharply in early 2026 on fears that artificial intelligence (AI) would disrupt per-seat software pricing, then rebounded strongly in recent weeks.
  • Recent momentum has favored TEAM, up roughly +74% in a month, versus a roughly +34% monthly gain for CRM.
  • CRM trades at a lower forward price-to-earnings (P/E) multiple and pays a dividend; TEAM carries a premium valuation with no dividend.
  • AI is a central catalyst for both: Agentforce for CRM, and Rovo plus the Teamwork Graph for TEAM.

Setting the Context for CRM and TEAM

CRM and TEAM both operate in enterprise software, yet they appeal to very different investor profiles. CRM is a cash-rich, large-cap franchise delivering double-digit growth and returning capital to shareholders, while TEAM is a growth-oriented developer of team-collaboration tools that is still converting its customer base to the cloud. Because both were caught in the same 2026 software sell-off and have since rebounded, comparing their relative performance and market positioning offers useful insight for traders and longer-term investors weighing value against growth in the current environment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

CRM Overview and Recent Performance

Salesforce, Inc. is the world's largest customer relationship management (CRM) software provider, helping businesses manage sales, service, and marketing workflows. In recent market activity, the stock staged a sharp recovery, rallying roughly +34% in a month after a weak first half of 2026, though it remains below its year-start level.

The rebound was driven by solid quarterly results showing revenue near $11.35 billion, up about 11% year over year, alongside accelerating AI momentum. Its Agentforce agentic-AI platform reached about $1.5 billion in annual recurring revenue (ARR), up more than 240% year over year, while combined Agentforce and Data 360 ARR approached $3.9 billion. Management raised full-year guidance and pointed to near-record-low customer attrition. Investors also note the company's $50 billion share repurchase authorization and a modest dividend. Sentiment has improved as AI is increasingly framed as a growth driver rather than a threat to its seat-based model. From what I see, the AI narrative shift here is worth monitoring closely.

TEAM Overview and Recent Performance

Atlassian Corporation provides collaboration and work-management software, including Jira, Confluence, and its Rovo AI assistant, underpinned by the Teamwork Graph. The stock climbed roughly +74% in a month after better-than-expected earnings, though it remains well below its prior all-time high and its start-of-year level.

The latest quarter showed revenue rising about 28% year over year to roughly $1.77 billion, led by cloud revenue growth above 30%. Subscription ARR reached about $6.6 billion, up 23%, while remaining performance obligations (RPO) rose 44% to about $4.8 billion. Net revenue retention exceeded 120%, and customers using Rovo are expanding ARR at roughly twice the rate of non-adopters. A key watch item is the planned wind-down of its on-premises data-center business by 2029, which management expects to temper near-term total revenue growth even as cloud momentum stays strong. I’m watching this closely as the cloud transition continues.

Head-to-Head Comparison

The contrast between these two names is primarily a trade-off between maturity and profitability versus growth and reinvestment. CRM generates substantial free cash flow and operating margin, trades near a forward P/E of roughly 16 times, and returns capital through a large buyback and a dividend. TEAM reinvests more heavily, carries a forward P/E near 28 times, and offers no dividend, but it is growing revenue at roughly 28% compared with CRM's low-double-digit pace.

Growth drivers also differ. CRM is monetizing AI agents through Agentforce and expanding into data infrastructure via acquisitions. TEAM is executing a multi-year cloud migration and using its Teamwork Graph to differentiate AI capabilities across technical and non-technical teams. On risk, CRM faces slower organic growth and competition from larger rivals, while TEAM's data-center wind-down creates a near-term revenue drag and its premium valuation leaves less room for error. Both remain exposed to the broader "SaaS" (software-as-a-service) AI-disruption debate that has reshaped software sentiment this year.

Exploring AI Tools for Stock Analysis

In my research process, I frequently turn to Tickeron’s AI tools to cross-check momentum and trends across names like these. One resource I often consult is the Trending AI Robots page, which highlights curated AI trading bots suited to current market conditions. These bots cover varied styles and strategies with published statistics on win rates and returns, helping align approaches with individual trading preferences in growth and AI-related themes.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRM, TEAM

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Aroon Indicator for CRM shows an upward move is likely

CRM's Aroon Indicator triggered a bullish signal on September 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 199 similar instances where the Aroon Indicator showed a similar pattern. In 158 of the 199 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 40 of 57 cases where CRM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The 50-day moving average for CRM moved above the 200-day moving average on September 15, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +5.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRM advanced for three days, in 226 of 327 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

Bearish Trend Analysis

The 10-day RSI Indicator for CRM moved out of overbought territory on September 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 16 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.

The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRM as a result. In 63 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The Moving Average Convergence Divergence Histogram (MACD) for CRM turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 31 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

CRM broke above its upper Bollinger Band on August 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.873) is normal, around the industry mean (51.456). P/E Ratio (20.812) is within average values for comparable stocks, (82.636). Projected Growth (PEG Ratio) (0.759) is also within normal values, averaging (3.135). Dividend Yield (0.008) settles around the average of (0.011) among similar stocks. P/S Ratio (5.107) is also within normal values, averaging (69.875).

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CRM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Salesforce (NYSE:CRM), Shopify Inc (NASDAQ:SHOP), Uber Technologies (NYSE:UBER), ServiceNow Inc. (NYSE:NOW), Datadog (NASDAQ:DDOG), Adobe (NASDAQ:ADBE), Intuit (NASDAQ:INTU), Workday (NASDAQ:WDAY), Atlassian Corp (NASDAQ:TEAM), Autodesk (NASDAQ:ADSK).

Industry description

Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.

Market Cap

The average market capitalization across the Packaged Software Industry is 9.9B. The market cap for tickers in the group ranges from 39 to 244.09B. SAPGF holds the highest valuation in this group at 244.09B. The lowest valued company is STIXF at 39.

High and low price notable news

The average weekly price growth across all stocks in the Packaged Software Industry was 1%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 9%. RPGL experienced the highest price growth at 166%, while WCT experienced the biggest fall at -84%.

Volume

The average weekly volume growth across all stocks in the Packaged Software Industry was 14%. For the same stocks of the Industry, the average monthly volume growth was 32% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 76
Price Growth Rating: 59
SMR Rating: 77
Profit Risk Rating: 94
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
CRM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of on-demand customer relationship management software technology

Industry PackagedSoftware

Industry
Packaged Software
Address
415 Mission Street
Phone
+1 415 901-7000
Employees
83334
Web
https://www.salesforce.com
Interact to see
Advertisement
In my view, JPM stands out as the largest U.S. bank by assets and market capitalization, commanding leading market shares across key segments. It holds approximately 11.1% of U.S. retail deposits, 23.6% of credit card sales volume, 8.4% of global investment banking fees, 11.8% of markets revenue, and 10% of treasury services revenue. This diversified "universal banking model" spans consumer and community banking, commercial and investment banking, and asset and wealth management, generating resilient revenue streams.
In recent sessions, WMT has held steady around $124, pulling back from February highs near $134. From what I see, this resilience stands out as the stock has outperformed broader indices year-to-date, thanks to its defensive role in groceries and essentials. Shoppers are leaning toward value options, and consistent volumes show ongoing institutional support. The premium valuation reflects confidence in Walmart's omnichannel progress and market share gains. Even with macro headwinds, I view WMT as a portfolio staple during uncertain times.
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
NKE shares are tumbling approximately 11% in premarket trading on April 1, 2026, sliding to near nine-year lows after the previous close of $52.82. The primary catalyst is Nike's weak Q4 fiscal 2026 guidance: management projected a 2%–4% revenue decline, sharply missing analyst expectations of approximately 1.9% growth.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
APTV shares are tumbling approximately 14% in premarket trading on April 1, 2026, representing one of the sharpest single-session losses in the stock's recent history. The primary catalyst is Aptiv's Board of Directors formally approving the long-anticipated spin-off of its Electrical Distribution Systems (EDS) business, now named Versigent, combined with the announcement of a $1.6 billion private offering of senior notes tied to the transaction.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
RH shares are down approximately 17% in premarket trading on April 1, 2026, after closing the previous session at $139.82, with the stock indicated near $115.76 — a decline of roughly $24 per share. The primary catalyst is a significant Q4 fiscal year 2025 earnings miss, with adjusted EPS of $1.53 coming in well below the Wall Street consensus of $2.22 — a 31% negative surprise.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ORIC Pharmaceuticals shares are down approximately 21% in premarket trading on April 1, 2026, from a prior session close of approximately $12.19, placing the premarket price near $9.63. The primary catalyst is the after-market release of Phase 1b dose optimization data for rinzimetostat (ORIC-944) on March 31, alongside the selection of 400 mg once daily as the recommended Phase 3 dose for the Himalayas-1 registrational trial.
Shares of Target Hospitality Corp. (Nasdaq: TH) surged approximately 38% during Wednesday's trading session, climbing from a prior close of $9.28 to approximately $12.81. The primary catalyst is the company's announcement of a landmark multi-year lease and services agreement worth over $550 million with a top-five global hyperscaler to build and operate a data center workforce community in North Texas.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".